Tinidazol

Gefahreninformationscode (GHS)

• Bildanzeige (GHS)

  

• Alarmwort

  Warnung

• Gefahrenhinweise

  H341：Kann vermutlich genetische Defekte verursachen.

  H351：Kann vermutlich Krebs verursachen.

• Sicherheit

  P201：Vor Gebrauch besondere Anweisungen einholen.

  P202：Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.

  P280：Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.

  P308+P313：BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

Tinidazole Chemische Eigenschaften,Einsatz,Produktion Methoden

• R-Sätze Betriebsanweisung:

  R20/21/22:Gesundheitsschädlich beim Einatmen,Verschlucken und Berührung mit der Haut.
  R40:Verdacht auf krebserzeugende Wirkung.

• S-Sätze Betriebsanweisung:

  S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
  S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.

• Chemische Eigenschaften

  solid

• Originator

  Simplotan,Pfizer,W. Germany,1971

• Verwenden

  For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestin

• Verwenden

  anti-ulcerative

• Verwenden

  anticonvulsant

• Verwenden

  Antiprotozoal (Trichomonas, Giardia); antiamebic; antibacterial.

• Definition

  ChEBI: Tinidazole is 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent. It has a role as an antiprotozoal drug, an antibacterial drug, an antiparasitic agent and an antiamoebic agent.

• Manufacturing Process

  The preparation of ethylsulfonylethyl-p-toluenesulfonate is carried out in the following manner: 69.0 grams (0.5 mol) ethylsulfonylethanol dissolved in 150 ml pyridine is cooled to 0°C with stirring and while maintaining the temperature between 0° to 10°C, 95 grams (0.5 mol) p-toluenesulfonyl chloride is added in portions over a 10 minute period. After this time, 250 ml water is added slowly and the mixture extracted with chloroform, the organic phase washed first with 2 N HCl, then with water, separated and dried. The product which crystallizes on cooling is filtered and dried to give 77.5% yield of this intermediate.
  A mixture of 12.7 grams (0.1 mol) of 2-methyl-5-nitroimidazole and 58.4 grams (0.2 mol) ethylsulfonylethyl-p-toluenesulfonate is heated with stirring, under nitrogen, at 145° to 150°C for about 4 hours. After this time, the reaction mixture is extracted with 500 ml hot water, the aqueous portion adjusted with 10% Na2CO3 to a pH of 9 and extracted with chloroform (3 times with 150 ml portions). The separated organic phase is washed with water, dried with Na2SO4 and evaporated to dryness. The crude tinidazole product is then crystallized from benzene to give 4.36 grams of product having a MP of 127° to 128°C.

• Therapeutic Function

  1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitroimidazole

• Antimicrobial activity

  Its antibacterial and antiprotozoal activity is similar to that of metronidazole.The MIC against G. vaginalis is 0.2–2 mg/L; the hydroxy metabolite is significantly more active than that of metronidazole. H. pylori is inhibited by 0.5 mg/L. T. vaginalis and T. fetus at 2.5 mg/L and E. histolytica is inhibited by about 0.3–2.5 mg/L.

• Pharmazeutische Anwendungen

  A 5-nitroimidazole available for oral administration and, in some countries, for intravenous infusion.

• Mechanism of action

  Tinidazole has a mechanism of action that parallels that of metronidazole as well as a similar metabolic pathway leading to hydroxylation at the 2-methyl group catalyzed by CYP3A4. Basically, tinidazole appears to mimic the actions of metronidazole, although there are reports that it is effective against some protozoa which are resistant to metronidazole.

• Pharmakokinetik

  Oral absorption ：>95%
  Cmax 2 g oral：40 mg/L after 2 h
  800 mg (30-min infusion)： 12 mg/L 6 min after end infusion
  Plasma half-life： 12–14 h
  Volume of distribution 0.64 L/kg ：Plasma protein binding 12%
  absorption and distribution
  After a 2 g oral dose, concentrations remain at c. 10 mg/L at 24 h and 2.5 mg/L at 48 h. Daily doses of 1 g maintain plasma levels in excess of 8 mg/L, irrespective of whether the dose is oral or intravenous. It is well distributed, with concentrations in bile, CSF, breast milk and saliva similar to those reached in plasma.
  The drug readily crosses the placenta. In women undergoing first trimester abortion, concentrations of 4.9 mg/kg (placenta) and 7.6 mg/kg (fetus) were found when the plasma concentration was 13.2 mg/L.
  Metabolism and excretion
  Metabolites include the 2-hydroxymethyl derivative, its glucuronide and two unidentified minor derivatives. In urine about half the drug remains unmetabolized.
  The parent drug and its metabolites are excreted primarily in the urine and to a minor extent in the feces. The clearance rate is about 0.73 mL/min per kg and the urinary excretion is about 21% of the dose. Total clearance of the drug is 51 mL/min, renal clearance 10 mL/min. In healthy volunteers given an ： intravenousinfusion of 800 mg [14C]tinidazole over 30 min, a mean of 44% of the dose was excreted in the urine during the first 24 h, increasing to 63% over 5 days： only 12% of the dose appeared in the feces. Unchanged tinidazole comprised 32% of urinary 14C in 0&ndash：12 h urine. The 2-hydroxymethyl metabolite accounted for about 9% of the urinary 14C and was also present in plasma.
  In renal failure the pharmacokinetics are not significantly different from those in healthy individuals. It is rapidly removed by hemodialysis and a normal dose should be given after each dialysis： if treatment precedes dialysis a half dose should be infused after the end of the procedure.

• Clinical Use

  Anaerobic bacterial infections(prophylaxis and treatment)
  Trichomoniasis
  Giardiasis (single dose) Amebiasis (including amebic liver abscess)
  Bacterial vaginosis
  Gastric colonization with H. pylori (in combination with other agents)

• Nebenwirkungen

  Tinidazole is generally well tolerated. Infrequent and transient effects include nausea, vomiting, diarrhea and a metallic taste. Disulfiram-like reactions may occur and rare neurological disturbances and transient leukopenia have been described. Rash, which may be severe, urticaria and angioneurotic edema can occur.

• Synthese

  Tinidazole, 1-2-(ethylsulfonyl)ethyl-2-methyl-5-nitroimidazole (37.2.12), is also made from 2-methyl-5-nitroimidazole (37.2.9), which upon being reacted with 2-ethoxysulfonyl-p-toluenesulfonate (37.2.11) transformed into the desired tinidazole.
  The 2-ethoxysulfonyl-p-toluenesulfonate (37.2.11) necessary for this reaction is in turn made by tosylation of 2-ethylsulfonyl ethanol using p-toluenesulfonyl chloride.

  

• Veterinary Drugs and Treatments

  Little information is presently available on the use of tinidazole in dogs, cats, or horses. It potentially could be useful for treating anaerobic infections, particularly associated with dental infections in small animals. Because of its antiprotozoal effects, it has been used as an alternative for treating giardiasis in small animals, and it could have efficacy against amebiasis, trichomoniasis or balantidiasis in veterinary species, but documentation of efficacy is not available. Tinidazole has a longer duration of action in dogs and cats than does metronidazole. In humans, oral tinidazole is FDA-approved for treating extraintestinal and intestinal amebiasis, (Entamoeba histolytica), giardiasis (Giardia duodenalis/lamblia), and trichomoniasis (T. vaginalis).

• Arzneimittelwechselwirkung

  Potentially hazardous interactions with other drugs
  Alcohol: disulfiram-like reaction.

• Stoffwechsel

  Tinidazole is excreted by the liver (up to 5
  %) and kidneys as unchanged drug and metabolites. An active hydroxy metabolite has been identified.

Tinidazole Upstream-Materialien And Downstream Produkte

Tinidazol Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(453)Suppliers

19387-91-8, Tinidazole Verwandte Suche: